- Home
- PAVM vs SACH Comparison
PAVM vs SACH Comparison
Compare PAVM & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | SACH |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.1M | 38.4M |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PAVM | SACH |
|---|---|---|
| Price | $2.80 | $0.84 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.50 | N/A |
| AVG Volume (30 Days) | 25.0K | ★ 146.2K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 23.19% |
| EPS Growth | N/A | ★ 104.30 |
| EPS | N/A | ★ N/A |
| Revenue | $3,000,000.00 | ★ $57,500,000.00 |
| Revenue This Year | $132.39 | $94.91 |
| Revenue Next Year | $263.64 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 20.00 | N/A |
| 52 Week Low | $0.21 | $0.76 |
| 52 Week High | $28.44 | $1.45 |
Technical Indicators
Market Signals| Indicator | PAVM | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 35.07 |
| Support Level | $0.21 | $0.77 |
| Resistance Level | $6.56 | $0.87 |
| Average True Range (ATR) | 0.33 | 0.03 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 12.00 | 8.33 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.